Literature DB >> 2320399

Glutaric acidemia type II: heterogeneity of clinical and biochemical phenotypes.

J P Loehr1, S I Goodman, F E Frerman.   

Abstract

We have examined 23 fibroblast lines from patients with neonatal and late onset glutaric acidemia type II and fibroblasts from four parents of these patients. Fifteen of these patients are previously unreported. Results of these investigations show deficiency of electron transfer flavoprotein or electron transfer flavoprotein-ubiquinone oxidoreductase activity in all of the patients' fibroblasts. Immunoblots indicate that the steady state levels of the antigens is very low or undetectable in most of the neonatal onset patients; however, cross-reacting antigen without electron transfer activity is observed in several glutaric acidemia type II fibroblast lines. Assay of parental lines confirm the autosomal transmission of deficiencies of proteins. Of particular interest is the clinical heterogeneity among these patients. Patients may present with an extrapyramidal movement disorder as observed in glutaric aciduria type I, without the typical organic aciduria typical of glutaric acidemia type II even in the presence of severe enzyme deficiency, or with renal cystic dysplasia accompanying electron transfer flavoprotein deficiency. Renal cystic dysplasia had previously been reported only in patients with electron transfer flavoprotein-ubiquinone oxidoreductase deficiency.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320399     DOI: 10.1203/00006450-199003000-00024

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  23 in total

1.  A public health response to emerging technology: expansion of the Massachusetts newborn screening program.

Authors:  K Atkinson; B Zuckerman; J M Sharfstein; D Levin; R J Blatt; H K Koh
Journal:  Public Health Rep       Date:  2001 Mar-Apr       Impact factor: 2.792

2.  Sudden cardiac arrest during induction of anaesthesia in paediatric patient with glutaric aciduria type II.

Authors:  Sema Şanal Baş; Gonca Kılıç Yıldırım
Journal:  Sudan J Paediatr       Date:  2020

3.  Congenital disorders of glycosylation type I: a rare but new cause of hyperechoic kidneys in infants and children due to early microcystic changes.

Authors:  Lucie Hertz-Pannier; Michele Déchaux; Martine Sinico; Sophie Emond; Valerie Cormier-Daire; Jean-Marie Saudubray; Francis Brunelle; Patrick Niaudet; Nathalie Seta; Pascale de Lonlay
Journal:  Pediatr Radiol       Date:  2005-11-22

4.  Disease mechanisms and protein structures in fatty acid oxidation defects.

Authors:  Niels Gregersen; Rikke K J Olsen
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

5.  Neonatal multiple acyl-CoA dehydrogenase deficiency: essentially absent fatty acid oxidation activity in proband but normal activity in parental cultured skin fibroblasts.

Authors:  W C Ip; J W Hammond; B Wilcken
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

6.  Three-dimensional structure of human electron transfer flavoprotein to 2.1-A resolution.

Authors:  D L Roberts; F E Frerman; J J Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Ethylene glycol monomethyl ether-induced toxicity is mediated through the inhibition of flavoprotein dehydrogenase enzyme family.

Authors:  Makoto Takei; Yosuke Ando; Wataru Saitoh; Tomoe Tanimoto; Naoki Kiyosawa; Sunao Manabe; Atsushi Sanbuissho; Osamu Okazaki; Haruo Iwabuchi; Takashi Yamoto; Klaus-Peter Adam; James E Weiel; John A Ryals; Michael V Milburn; Lining Guo
Journal:  Toxicol Sci       Date:  2010-07-08       Impact factor: 4.849

8.  Newborn Screening for Glutaric Aciduria-II: The New England Experience.

Authors:  I Sahai; C L Garganta; J Bailey; P James; H L Levy; M Martin; E Neilan; C Phornphutkul; D A Sweetser; T H Zytkovicz; R B Eaton
Journal:  JIMD Rep       Date:  2013-11-05

9.  Increased prevalence of hereditary metabolic diseases among native Indians in Manitoba and northwestern Ontario.

Authors:  J C Haworth; L A Dilling; L E Seargeant
Journal:  CMAJ       Date:  1991-07-15       Impact factor: 8.262

10.  Combined enzyme defect of mitochondrial fatty acid oxidation.

Authors:  S Jackson; R S Kler; K Bartlett; H Briggs; L A Bindoff; M Pourfarzam; D Gardner-Medwin; D M Turnbull
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.